Subscribe to our newsletter to receive the latest product updates and special offers

Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

NEW: Revenue Breakdown and Options Chain

Gain deeper insights into company revenues with a detailed analysis of revenue sources.
Explore the updated Options feature, providing in-depth data, and a 3D viewing option.

Last Close
Mar 28 09:43AM ET
2.12
Dollar change
+0.06
Percentage change
2.91
%
Index- P/E- EPS (ttm)-0.38 Insider Own82.17% Shs Outstand35.25M Perf Week-23.47%
Market Cap46.58M Forward P/E- EPS next Y-0.02 Insider Trans0.00% Shs Float3.92M Perf Month-18.46%
Income-13.34M PEG- EPS next Q-0.15 Inst Own12.03% Short Float10.43% Perf Quarter225.60%
Sales36.08M P/S1.29 EPS this Y69.08% Inst Trans2.52% Short Ratio1.12 Perf Half Y192.41%
Book/sh0.64 P/B3.31 EPS next Y82.98% ROA-20.68% Short Interest0.41M Perf Year196.05%
Cash/sh1.86 P/C1.14 EPS next 5Y- ROE-48.92% 52W Range0.45 - 3.25 Perf YTD193.22%
Dividend Est.- P/FCF- EPS past 5Y18.79% ROI-58.09% 52W High-34.77% Beta1.61
Dividend TTM- Quick Ratio1.79 Sales past 5Y25.79% Gross Margin99.65% 52W Low371.11% ATR (14)0.35
Dividend Ex-Date- Current Ratio1.79 EPS Y/Y TTM79.80% Oper. Margin-40.24% RSI (14)44.01 Volatility19.83% 15.57%
Employees44 Debt/Eq0.04 Sales Y/Y TTM128.97% Profit Margin-36.96% Recom1.00 Target Price6.50
Option/ShortYes / Yes LT Debt/Eq0.02 EPS Q/Q-182.53% Payout- Rel Volume0.82 Prev Close2.06
Sales Surprise43.36% EPS Surprise58.21% Sales Q/Q-41.55% EarningsMar 25 AMC Avg Volume365.41K Price2.12
SMA20-15.61% SMA5010.96% SMA200109.93% Trades Volume24,426 Change2.91%
Date Action Analyst Rating Change Price Target Change
Oct-29-21Resumed Stifel Buy $12
Sep-15-21Initiated Cantor Fitzgerald Overweight $14
Jul-14-20Reiterated H.C. Wainwright Buy $14 → $24
Jul-10-20Resumed Stifel Buy $22 → $10
Feb-22-19Initiated SVB Leerink Outperform $16
Mar-25-24 09:53PM
05:10PM
04:01PM
Mar-22-24 08:00AM
Jan-29-24 04:07AM
09:52AM Loading…
Dec-21-23 09:52AM
08:00AM
Nov-20-23 11:23AM
Nov-13-23 09:00AM
Nov-08-23 04:01PM
Nov-06-23 08:00AM
Oct-24-23 12:30PM
Oct-19-23 08:00AM
Oct-16-23 08:00AM
Oct-03-23 08:00AM
08:00AM Loading…
Oct-02-23 08:00AM
Sep-20-23 08:00AM
Aug-30-23 08:00AM
Aug-12-23 08:05AM
Aug-09-23 05:30PM
04:01PM
Aug-02-23 04:00PM
Jun-01-23 08:00AM
May-15-23 08:00AM
May-11-23 05:25PM
04:01PM
May-03-23 06:14AM
Apr-24-23 08:00AM
Mar-23-23 04:01PM
Mar-22-23 08:00AM
08:00AM Loading…
Feb-17-23 08:00AM
Feb-07-23 08:00AM
Jan-13-23 08:00AM
Dec-23-22 04:01PM
Dec-16-22 08:00AM
Dec-06-22 12:17PM
07:00AM
Nov-14-22 04:01PM
08:00AM
Nov-10-22 08:00AM
Nov-08-22 08:00AM
Nov-03-22 08:00AM
Nov-02-22 08:00AM
Oct-26-22 08:00AM
Sep-27-22 08:15AM
08:04AM
07:00AM
Sep-15-22 08:00AM
Sep-07-22 05:58AM
Sep-06-22 04:00PM
Aug-31-22 08:00AM
Aug-18-22 07:48AM
Aug-15-22 04:01PM
Jul-28-22 08:00AM
Jun-14-22 02:09PM
May-17-22 08:00AM
May-12-22 04:01PM
08:00AM
May-09-22 08:00AM
Apr-25-22 08:00AM
Apr-04-22 08:00AM
Mar-29-22 10:00AM
Mar-28-22 12:00PM
Mar-24-22 08:00AM
Mar-23-22 04:01PM
01:42PM
Mar-04-22 08:00AM
Mar-01-22 08:00AM
Feb-16-22 11:22AM
07:00AM
Feb-15-22 08:00AM
Feb-09-22 08:00AM
Feb-02-22 06:46AM
Jan-10-22 08:00AM
Jan-05-22 08:00AM
Jan-04-22 12:48PM
11:39AM
08:00AM
Dec-13-21 08:00AM
Nov-09-21 08:00AM
Nov-05-21 08:00AM
08:00AM
Nov-04-21 09:00AM
Nov-02-21 11:23AM
08:00AM
Oct-18-21 08:00AM
Sep-30-21 08:00AM
Sep-22-21 08:00AM
Sep-08-21 08:00AM
Aug-11-21 04:00PM
Aug-10-21 04:01PM
Aug-06-21 04:42AM
Aug-05-21 08:00AM
Jul-13-21 09:10AM
Jul-12-21 04:01PM
Jun-11-21 09:53AM
07:00AM
Jun-10-21 08:00AM
Jun-09-21 08:00AM
Jun-07-21 08:00AM
Equillium, Inc. engages in the development of products for severe autoimmune and inflammatory, or immuno-inflammatory, disorders with high unmet medical need. Its product pipeline includes EQ001, which is a monoclonal antibody that selectively targets the novel immune checkpoint receptor CD6. The company was founded by Daniel Mark Bradbury, Bruce D. Steel, and Stephen Connelly on March, 2017 and is headquartered in La Jolla, CA.